Cargando…
Recombinant VP1, an Akt Inhibitor, Suppresses Progression of Hepatocellular Carcinoma by Inducing Apoptosis and Modulation of CCL2 Production
BACKGROUND: The application of viral elements in tumor therapy is one facet of cancer research. Recombinant capsid protein VP1 (rVP1) of foot-and-mouth disease virus has previously been demonstrated to induce apoptosis in cancer cell lines. Here, we aim to further investigate its apoptotic mechanism...
Autores principales: | Chen, Tai-An, Wang, Jui-Ling, Hung, Shao-Wen, Chu, Chiao-Li, Cheng, Yung-Chih, Liang, Shu-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149645/ https://www.ncbi.nlm.nih.gov/pubmed/21826248 http://dx.doi.org/10.1371/journal.pone.0023317 |
Ejemplares similares
-
Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7
por: Ho, Ming-Yi, et al.
Publicado: (2014) -
Albumin fibrillization induces apoptosis via integrin/FAK/Akt pathway
por: Huang, Chun-Yung, et al.
Publicado: (2009) -
Recombinant VP1 regulates migration of cancer cells and macrophages differentially via let-7a and MMP-9
por: Liang, Shu-Mei, et al.
Publicado: (2015) -
13-Acetoxysarcocrassolide induces apoptosis in human hepatocellular carcinoma cells through mitochondrial dysfunction and suppression of the PI3K/AKT/mTOR/p70S6K signalling pathway
por: Hsu, Chang-Min, et al.
Publicado: (2022) -
CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop
por: Meng, Jin, et al.
Publicado: (2021)